Sanofi Genzyme is a leader in life sciences, focusing on the development of the treatment for rare diseases. According to media sources, Sanofi Genzyme has indicated that it is investing more than $300 million into the Framingham facility and technology; streamlining its processes and adjusting staffing levels. Sanofi Genzyme has expressed its commitment to the City of Framingham
There are no replies in this thread yet. Be the first to post a reply below: